Molly® 2.25 is a large-volume variant of the Molly autoinjector to accommodate larger-volume biologics. Featuring the same easy-to-use, two-step operation, it inherited the modular platform development model to support high-volume manufacturing, faster development, and flexible design for unique branding needs.
We work with 12+ pharmaceutical companies to commercialise our Molly® and Molly® 2.25 autoinjectors. Seventeen combination products have been approved so far, including the world’s first large-volume autoinjector with a ≥2.0mL fill.
Key features
- Simple two-step operation
- Needle cover activation
- Audible, visual and tactile feedback
- One-handed operation
- Larger volume
- Permanently hidden needle
- Ergonomic cap removal
- Robust anti-roll design